MERILOG 100 [iU]/mL
insulin aspart-szjj · INJECTION, SOLUTION · Sanofi-Aventis U.S. LLC
MERILOG is a injection, solution containing insulin aspart-szjj at 100 [iU]/mL, taken intravenous. Manufactured by Sanofi-Aventis U.S. LLC.
Key Facts
- Brand Name
- MERILOG
- Generic Name
- insulin aspart-szjj
- NDC Code (Product)
0024-5927- Manufacturer
- Sanofi-Aventis U.S. LLC
- Strength
- 100 [iU]/mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS, SUBCUTANEOUS
- Marketing Status
- Application #
- BLA761325
- Drug Class
- Insulin Analog [EPC]
- Marketing Start
- 02/14/2025
Recall History
No Recall HistoryFrequently Asked Questions
What is MERILOG used for?
MERILOG contains insulin aspart-szjj. It is a injection, solution taken intravenous. Consult your doctor for specific uses.
Is MERILOG a controlled substance?
MERILOG is not classified as a controlled substance by the DEA.
What is the generic name for MERILOG?
The generic name for MERILOG is insulin aspart-szjj. There are no other listed brand versions of insulin aspart-szjj.
What is the NDC code for MERILOG 100 [iU]/mL?
The NDC (National Drug Code) for MERILOG 100 [iU]/mL is 0024-5927, listed by Sanofi-Aventis U.S. LLC.
Other MERILOG Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)